Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 14/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410354 | 0.75 | TGM2 (0.46) | — | |
| SCHEMBL25247069 | 0.75 | TGM2 (0.46) | — | |
| SCHEMBL27361372 | 0.74 | UCHL3 (0.51) | WDR5EGFRUCHL3SMN1; SMN2GAA | |
| SCHEMBL16634492 | 0.74 | TGM2 (0.42) | — | |
| SCHEMBL25394386 | 0.73 | SMN1; SMN2 (0.42) | WDR5KDM4ESMN1; SMN2GAA | |
| SCHEMBL30599328 | 0.73 | SMN1; SMN2 (0.42) | WDR5KDM4ESMN1; SMN2GAA | |
| SCHEMBL30599296 | 0.73 | SMN1; SMN2 (0.48) | WDR5SMN1; SMN2GAA | |
| SCHEMBL25395848 | 0.73 | SMN1; SMN2 (0.42) | WDR5KDM4ESMN1; SMN2GAA | |
| SCHEMBL25397477 | 0.73 | SMN1; SMN2 (0.48) | WDR5SMN1; SMN2GAA | |
| SCHEMBL30599307 | 0.73 | SMN1; SMN2 (0.48) | WDR5SMN1; SMN2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023166303-A1 | ACRYLAMIDE COMPOUNDS | NRG THERAPEUTICS LTD (GB) | 2023-09-07 | — | — | WO | disclosed |